Birth Outcomes for Pregnant Women with HIV Using Tenofovir–Emtricitabine

BACKGROUND: In a previous trial of antiretroviral therapy (ART) involving pregnant women with human immunodeficiency virus (HIV) infection, those randomly assigned to receive tenofovir, emtricitabine, and ritonavir-boosted lopinavir (TDF–FTC–LPV/r) had infants at greater risk for very premature birt...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:N Engl J Med
Asıl Yazarlar: Rough, Kathryn, Seage, George R., Williams, Paige L., Hernandez-Diaz, Sonia, Huo, Yanling, Chadwick, Ellen G., Currier, Judith S., Hoffman, Risa M., Barr, Emily, Shapiro, David E., Patel, Kunjal
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5984044/
https://ncbi.nlm.nih.gov/pubmed/29694825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1701666
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller